Richard Waldron, EVP & CFO at Sciclone Pharmaceuticals, holds 0.00 shares in Sciclone Pharmaceuticals (Ticker: SCLN), holds 230.92K shares in BioAtla (Ticker: BCAB). Most recently, Richard Waldron ― shares of Sciclone Pharmaceuticals on ― for an estimated value of ―.